Trials / Unknown
UnknownNCT03786965
Evaluating of Role of Myeloperoxidase in Prediction of Outcomes of Cardiac Surgery Procedures.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,000 (estimated)
- Sponsor
- St. Petersburg State Pavlov Medical University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The main objection is to investigate molecular biology of myocardial damage during cardiac surgery procedures.
Detailed description
To assess outcomes after cardiac surgery procedures. To investigate serum level of myeloperoxidase, morphology of left atrium appendage, to perform genetic analysis and cell biology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | On-pump CABG | On-pump CABG |
| OTHER | Off-pump CABG | Off-pump CABG |
| OTHER | Pump-assisted CABG | Pump-assisted CABG |
| OTHER | Valve Repair Procedure without CABG. | Valve Repair Procedure without CABG (open heart procedure). |
| OTHER | Valve Repair Procedure with CABG. | Valve Repair Procedure with CABG (open heart procedure). |
Timeline
- Start date
- 2018-12-20
- Primary completion
- 2025-07-20
- Completion
- 2025-12-20
- First posted
- 2018-12-26
- Last updated
- 2021-11-16
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT03786965. Inclusion in this directory is not an endorsement.